Top Markets
#1 OriginTrail OriginTrail +34.00%
#2 Tutorial Tutorial +12.08%
#3 MarsCoin MarsCoin +11.70%
#4 Waves Waves +10.84%
#5 Pons Pons +8.58%
#6 Siren Siren +8.36%
#7 Synapse Synapse +7.21%
#8 Cortex Cortex +7.15%
#9 Euler Euler +6.25%
#10 TROLL TROLL +6.08%
Coin of the day
OriginTrail OriginTrail
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Classifica tra le azioni #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Prezzo delle azioni
$0.49606484
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$88.47M
Variazione (1 giorno)
-1.58%
Variazione (1 anno)
-22.51%
Paese
TW
Scambia Intech Biopharm Corporation (6461)

Categoria

Healthcare
Rapporto P/S per Intech Biopharm Corporation (6461)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Intech Biopharm Corporation, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Intech Biopharm Corporation da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH